[HTML][HTML] Effect of salidroside on neuroprotection and psychiatric sequelae during the COVID-19 pandemic: a review

T Zhu, H Liu, S Gao, N Jiang, S Chen, W Xie - Biomedicine & …, 2024 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic has affected the mental
health of individuals worldwide, and the risk of psychiatric sequelae and consequent mental …

[HTML][HTML] Pharmacological effects of salidroside on central nervous system diseases

M Jin, C Wang, Y Xu, Z Zhang, X Wu, R Ye… - Biomedicine & …, 2022 - Elsevier
Salidroside (SAL) is a phenylpropanoid glycoside monomer extracted from Rhodiola at high
altitudes. It has been proven to have protective effects on myocardial injury, liver cancer …

The anti-inflammatory effect of the tricyclic antidepressant clomipramine and its high penetration in the brain might be useful to prevent the psychiatric consequences …

B Nobile, M Durand, E Olié, S Guillaume… - Frontiers in …, 2021 - frontiersin.org
At the time of writing (December 2020), coronavirus disease 2019 (COVID-19) has already
caused more than one million deaths worldwide, and therefore, it is imperative to find …

Salidroside improves chronic stress induced depressive symptoms through microglial activation suppression

Y Fan, Y Bi, H Chen - Frontiers in Pharmacology, 2021 - frontiersin.org
Depression is a severe neurological disorder highly associated with chronic mental stress
stimulation, which involves chronic inflammation and microglial activation in the central …

Glycyrrhizin and boswellic acids, the golden nutraceuticals: multitargeting for treatment of mild–moderate COVID-19 and prevention of post-COVID cognitive …

AA Gomaa, YA Abdel-Wadood, MA Gomaa - Inflammopharmacology, 2022 - Springer
Breakthrough infections have been reported in fully vaccinated persons. Furthermore,
rebound symptoms have been reported following the new FDA granted emergency use to …

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal

GES Batiha, HM Al-Kuraishy, AI Al-Gareeb… - …, 2023 - Springer
Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …

Multi-target drugs for the treatment of cognitive impairment and fatigue in post-COVID syndrome: focus on Ginkgo biloba and Rhodiola rosea

JK Mueller, WE Müller - Journal of Neural Transmission, 2024 - Springer
Cognitive impairment, depression and (mental) fatigue represent the most frequent
neuropsychiatric symptoms of the post-COVID syndrome. Neuroinflammation, oxidative …

Clomipramine could be useful in preventing neurological complications of SARS-CoV-2 infection

B Nobile, M Durand, E Olié, S Guillaume… - Journal of Neuroimmune …, 2020 - Springer
Dear Dr. Gendelman, The global pandemic of the new coronavirus disease 2019 (COVID-
19) has affected more than 7 million of people and provoked more than 400,000 deaths …

Candidate psychotropics against SARS–CoV–2: A narrative review

M Khosravi - Pharmacopsychiatry, 2022 - thieme-connect.com
Since few therapeutic options are clinically accessible for coronavirus disease 2019 (COVID-
19), effective, safe, and globally available pharmaceuticals need to be urgently developed to …

Neuroprotective effect of salidroside against central nervous system inflammation‐induced cognitive deficits: A pivotal role of sirtuin 1‐dependent N rf‐2/HO‐1/NF‐κ B …

N Xu, F Huang, C Jian, L Qin, F Lu… - Phytotherapy …, 2019 - Wiley Online Library
Central nervous system (CNS) inflammation occurs in cognitive dysfunctions, but the
underlying mechanisms remain unclear. Here, we investigated the role of sirtuin 1 (SIRT1) …